申请人:H. Lundbeck A/S
公开号:US20170291874A1
公开(公告)日:2017-10-12
The present invention relates to the preparation of N-(2-(6-fluoro-1H-indol-3-yl)-ethyl)-3-(2,2,3,3-tetrafluoropropoxy)-benzylamine (Compound I), INN-name idalopirdine, and pharmaceutically acceptable salts thereof:
本发明涉及制备N-(2-(6-氟-1H-吲哚-3-基)-乙基)-3-(2,2,3,3-四氟丙氧基)-苯甲胺(化合物I),INN名称idalopirdine及其药学上可接受的盐: